>
Interview 1991 - The Origins of the Philosophy of Liberty with Ken Schoolland
Silversqueeze: How We Got Here, Where We're Going
I asked Grok for Its Opinion on "Grok vs ChatGPT, Which Is Better?"
You'll own NOTHING and be happy?
Build a Greenhouse HEATER that Lasts 10-15 DAYS!
Look at the genius idea he came up with using this tank that nobody wanted
Latest Comet 3I Atlas Anomolies Like the Impossible 600,000 Mile Long Sunward Tail
Tesla Just Opened Its Biggest Supercharger Station Ever--And It's Powered By Solar And Batteries
Your body already knows how to regrow limbs. We just haven't figured out how to turn it on yet.
We've wiretapped the gut-brain hotline to decode signals driving disease
3D-printable concrete alternative hardens in three days, not four weeks
Could satellite-beaming planes and airships make SpaceX's Starlink obsolete?

Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.